| pubmed-article:21810649 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21810649 | lifeskim:mentions | umls-concept:C0002395 | lld:lifeskim |
| pubmed-article:21810649 | lifeskim:mentions | umls-concept:C0085631 | lld:lifeskim |
| pubmed-article:21810649 | lifeskim:mentions | umls-concept:C0886883 | lld:lifeskim |
| pubmed-article:21810649 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
| pubmed-article:21810649 | lifeskim:mentions | umls-concept:C0599946 | lld:lifeskim |
| pubmed-article:21810649 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:21810649 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:21810649 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:21810649 | pubmed:dateCreated | 2011-8-3 | lld:pubmed |
| pubmed-article:21810649 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21810649 | pubmed:abstractText | Agitation and psychosis are common in Alzheimer disease and cause considerable morbidity. We attempted to delay or to prevent agitation and psychosis with the use of divalproex sodium (valproate). | lld:pubmed |
| pubmed-article:21810649 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21810649 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21810649 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21810649 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21810649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21810649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21810649 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21810649 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:21810649 | pubmed:issn | 1538-3636 | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:JackClifford... | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:ThomasRonald... | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:WeinerMichael... | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:AisenPaul SPS | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:CummingsJeffr... | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:RamanRemaR | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:SchneiderLon... | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:TariotPierre... | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:FleisherAdamA | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:LoyRebekahR | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:ThalLeonL | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:PorsteinssonA... | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:IsmailM... | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:JakimovichLau... | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:Alzheimer's... | lld:pubmed |
| pubmed-article:21810649 | pubmed:author | pubmed-author:BartocciBarba... | lld:pubmed |
| pubmed-article:21810649 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21810649 | pubmed:volume | 68 | lld:pubmed |
| pubmed-article:21810649 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21810649 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21810649 | pubmed:pagination | 853-61 | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:meshHeading | pubmed-meshheading:21810649... | lld:pubmed |
| pubmed-article:21810649 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21810649 | pubmed:articleTitle | Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. | lld:pubmed |
| pubmed-article:21810649 | pubmed:affiliation | Banner Alzheimer's Institute, 901 E Willetta St., Phoenix, AZ 85006, USA. pierre.tariot@bannerhealth.com | lld:pubmed |
| pubmed-article:21810649 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21810649 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:21810649 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21810649 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:21810649 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
